SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.07.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.07.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.07.14 | Novartis buy | UBS AG | |
| 14.07.14 | Novartis buy | Jefferies & Company Inc. | |
| 14.07.14 | Novartis buy | Jefferies & Company Inc. | |
| 09.07.14 | Roche kaufen | Independent Research GmbH | |
| 07.07.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 07.07.14 | Roche overweight | JP Morgan Chase & Co. | |
| 07.07.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 02.07.14 | Novartis Hold | Deutsche Bank AG | |
| 02.07.14 | Novartis buy | UBS AG | |
| 02.07.14 | Roche buy | UBS AG | |
| 01.07.14 | Roche overweight | JP Morgan Chase & Co. | |
| 30.06.14 | Roche buy | Société Générale Group S.A. (SG) | |
| 27.06.14 | BB Biotech kaufen | Independent Research GmbH | |
| 23.06.14 | Roche Hold | S&P Capital IQ | |
| 20.06.14 | Novartis Underweight | Morgan Stanley | |
| 19.06.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 19.06.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.06.14 | Novartis buy | UBS AG | |
| 18.06.14 | Novartis Outperform | Bernstein Research | |
| 09.06.14 | Novartis Equal weight | Barclays Capital | |
| 04.06.14 | Novartis Hold | Deutsche Bank AG | |
| 04.06.14 | Roche buy | Deutsche Bank AG | |
| 03.06.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 03.06.14 | Roche overweight | JP Morgan Chase & Co. | |
| 03.06.14 | Novartis Halten | Independent Research GmbH | |
| 02.06.14 | Roche buy | Société Générale Group S.A. (SG) | |
| 02.06.14 | Novartis Underweight | Morgan Stanley | |
| 02.06.14 | Roche overweight | Morgan Stanley | |
| 27.05.14 | Novartis Outperform | BNP PARIBAS | |
| 27.05.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 16.05.14 | Roche buy | UBS AG | |
| 16.05.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.05.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 15.05.14 | Novartis Underweight | Morgan Stanley | |
| 15.05.14 | Roche overweight | Morgan Stanley | |
| 15.05.14 | Novartis Hold | Deutsche Bank AG | |
| 15.05.14 | Roche buy | Deutsche Bank AG | |
| 13.05.14 | Novartis Neutral | Goldman Sachs Group Inc. |